MedPath

Quratis Inc.

Quratis Inc. logo
🇰🇷South Korea
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:1
Completed:0

Trial Phases

2 Phases

Phase 1:3
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (75.0%)
Phase 2
1 (25.0%)

ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74

Phase 1
Recruiting
Conditions
Tuberculosis, Pulmonary
Interventions
Biological: Placebo
First Posted Date
2024-12-03
Last Posted Date
2025-06-17
Lead Sponsor
Quratis Inc.
Target Recruit Count
144
Registration Number
NCT06714513
Locations
🇰🇷

Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Gyeonggi-do, Korea, Republic of

🇰🇷

Yonsei University Severance Hospital, Seoul, Korea, Republic of

🇰🇷

The Catholic University of Korea Seoul ST.MARY'S Hospital, Seoul, Korea, Republic of

and more 1 locations

Study to Assess Safety, Reactogenicity and Immunogenicity of the repRNA(QTP104) Vaccine Against SARS-CoV-2(COVID-19)

Phase 1
Active, not recruiting
Conditions
COVID-19
SARS-CoV-2
First Posted Date
2023-05-25
Last Posted Date
2023-05-25
Lead Sponsor
Quratis Inc.
Target Recruit Count
36
Registration Number
NCT05876364
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

🇰🇷

Gangnam Severance Hospital, Seoul, Korea, Republic of

Phase 2a Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Healthcare Workers

Phase 2
Conditions
Tuberculosis
First Posted Date
2019-01-16
Last Posted Date
2019-05-31
Lead Sponsor
Quratis Inc.
Target Recruit Count
107
Registration Number
NCT03806686
Locations
🇰🇷

Ajou University Hospital, Gyeonggi-do, Korea, Republic of

🇰🇷

Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

🇰🇷

Chung-Ang University Hospital, Seoul, Korea, Republic of

Phase 1 Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Adolescent

Phase 1
Conditions
Tuberculosis
First Posted Date
2019-01-16
Last Posted Date
2019-07-23
Lead Sponsor
Quratis Inc.
Target Recruit Count
36
Registration Number
NCT03806699
Locations
🇰🇷

HALLYM UNIV. Chuncheon Sacred Heart Hospital, Chuncheon, Korea, Republic of

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.